Soligenix
SNGX
#10367
Rank
S$15.68 M
Marketcap
S$1.56
Share price
0.83%
Change (1 day)
-50.23%
Change (1 year)

Earnings for Soligenix (SNGX)

Earnings in 2025 (TTM): -S$16.34 Million

According to Soligenix's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$12.02 Million a decrease over its 2023 earnings that were of -S$9.78 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Soligenix from 1998 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$16.34 Million35.97%
2024 -S$12.02 Million22.96%
2023 -S$9.78 Million-45.74%
2022 -S$18.01 Million11.88%
2021 -S$16.1 Million-32.37%
2020 -S$23.8 Million83.18%
2019 -S$13 Million11.57%
2018 -S$11.65 Million19.29%
2017 -S$9.77 Million33%
2016 -S$7.34 Million-19.7%
2015 -S$9.14 Million5.16%
2014 -S$8.7 Million
2010 -S$9.81 Million26.12%
2009 -S$7.78 Million75.1%
2008 -S$4.45 Million-45.38%
2007 -S$8.14 Million-22.84%
2006 -S$10.54 Million66.15%
2005 -S$6.35 Million-16.65%
2004 -S$7.62 Million13.28%
2003 -S$6.72 Million-11.88%
2002 -S$7.63 Million-59.44%
2001 -S$18.8 Million378.18%
2000 -S$3.94 Million-38.53%
1999 -S$6.4 Million-18.43%
1998 -S$7.85 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$43.12 B-271,360.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$13.10 B-82,500.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$9.89 B-62,347.25%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-S$23.34 Million 46.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-S$53.68 Million 237.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$2.76 B-17,498.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Cleveland BioLabs
CBLI
-S$3.54 Million-77.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.21 B-1,436.42%๐Ÿ‡บ๐Ÿ‡ธ USA